Authorization

Exact Sciences Announces Preliminary Fourth Quarter 2019 Results

MADISON, Wis., Jan. 12, 2020 /PRNewswire/ --A Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $294 million and $296 million for the fourth quarter ended Dec. 31, 2019.
Exact Sciences Announces Preliminary Fourth Quarter 2019 Results
"Building off a transformative 2019, Exact Sciences is uniquely positioned to change the way cancer is diagnosed and treated," said Kevin Conroy, chairman and CEO of Exact Sciences. "Following our combination with Genomic Health, we have the leading scientific minds, an experienced commercial team with deep relationships, and the global footprint necessary to support the growth of current and future cancer diagnostics. We've never been more excited about the future of Exact Sciences."Preliminary, Unaudited Fourth-Quarter 2019 Financial ResultsFor the three-month period ended December 31, 2019, as compared to the same period of 2018 (where applicable):
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
282930